Office of Naval Research Awards Second Phase of Research Contract to TASER International Inc.; ONR Releases First $74,500 of $348,000 in Second Phase Funding.

Business Editors

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Sept. 13, 2002

TASER(R) International Inc. (Nasdaq: TASR)(Nasdaq: TASRW), a provider of advanced less-lethal weapons for use in the law enforcement, private security and personal defense markets, was approved to begin the second phase of its research contract from the Office of Naval Research in conjunction with Marine Corps Systems Command.

The contract will fund research into advanced less-lethal weapons using TASER International's core Electro-Muscular Disruption (EMD) technology. The research under the second phase of the contract should be completed within 18 months. The second phase research is budgeted for $348,602.

The current approval includes the first $74,500 in funding, the remainder of the second phase budget is expected to be released from budget funds from the coming fiscal year starting Oct. 1, 2002.

"To continue our research efforts with the Office of Naval Research and Marine Corps Systems Command is very exciting," commented Rick Smith, CEO of TASER International Inc. "Given that our Phase 1 research was originally scheduled to take one year, we are encouraged that the Office of Naval Research elected to approve the beginning of Phase 2 less than five months into Phase 1.

"While we anticipate completion of Phase 1 research in November 2002, our preliminary results are very encouraging, as evidenced by the early initiation of Phase 2.

"We believe this contract further validates our technology, and will lead to potential significant long-term sales to various military agencies if the research results continue to be as favorable as they have been to date," Smith continued.

"Our policy on new product development and research is to maintain a high degree of confidentiality. Accordingly, we will not disclose the specifics of the research under this contract until the technology is ready for commercialization."

About TASER International Inc.

TASER International Inc. provides advanced less-lethal weapons for use in the law enforcement, private security, and personal defense markets. Its flagship ADVANCED TASER(R) product uses proprietary technology to incapacitate dangerous, combative, or high-risk subjects that may be impervious to other less-lethal means.

This technology reduces injury rates to suspects and officers, thereby lowering liability risk and improving officer safety. The ADVANCED TASER is currently in testing or deployment at over 1,600 law enforcement and correctional agencies in the United States and Canada. For more information, www.TASER.com.

Certain statements contained in this document may be deemed to be forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995, and TASER International intends that such forward-looking statements be subject to the safe-harbor created thereby.

Such forward-looking statements relate to: 1) expected revenue and earnings growth; 2) the company's estimates regarding the size of its target markets; 3) the ability of TASER to successfully penetrate the law enforcement market; 4) the growth expectations for existing accounts; 5) the ability of TASER to expand its product sales to the private security, military and consumer self-defense markets; and 6) the company's target business model.

TASER cautions that these statements are qualified by important factors that could cause actual results to differ materially from those reflected by the forward-looking statements herein.

Such factors include, but are not limited to: 1) market acceptance of the company's products; 2) TASER's ability to establish and expand its direct and indirect distribution channels; 3) TASER's ability to attract and retain the endorsement of key opinion leaders in the law enforcement community; 4) the level of product technology and price competition for the company's ADVANCED TASER product; 5) the degree and rate of growth of the markets in which TASER competes and the accompanying demand for its products; and 6) other factors detailed in the company's filings with the Securities and Exchange Commission.